Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Cleveland Clinic Journal of Medicine|March 1, 1991
Asthma: current strategies for treatmentT F Reiss, M AhmadChest|May 1, 1990
Abnormal lung gallium-67 uptake preceding pulmonary physiologic impairment in an asymptomatic patient with Pneumocystis carinii pneumoniaT F Reiss, J GoldenThe European Respiratory Journal|May 4, 2001
Correlation of airway obstruction and patient-reported endpoints in clinical studiesS Shingo, J Zhang, T F ReissChest|July 1, 1983
Pericarditis associated with Hemophilus influenzae type B pneumonia and bacteremia in two adultsB S Graham, T F Reiss, D W GregoryThe European Respiratory Journal|November 27, 2002
Variability and lack of predictive ability of asthma end-points in clinical trialsJ Zhang, C Yu, S T Holgate, et al.The American Review of Respiratory Disease|February 1, 1990
Short-term exposure to 0.3 ppm nitrogen dioxide does not potentiate airway responsiveness to sulfur dioxide in asthmatic subjectsI Rubinstein, B G Bigby, T F Reiss, et al.Life Sciences|January 1, 1991
Infection of cultured human airway epithelial cells by influenza A virusT F Reiss, D C Gruenert, J A Nadel, et al.The European Respiratory Journal|September 18, 1999
What are minimal important changes for asthma measures in a clinical trial?N C Santanello, J Zhang, B Seidenberg, et al.Clinical Pharmacology and Therapeutics|December 9, 1997
Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing intervalE A Bronsky, J P Kemp, J Zhang, et al.The Journal of Allergy and Clinical Immunology|September 13, 2000
Montelukast adult (10-mg film-coated tablet) and pediatric (5-mg chewable tablet) dose selectionsB Knorr, S Holland, J D Rogers, et al.Pageof 5